Refine by
Patient Access Articles & Analysis
31 articles found
By directing the immune system to attack cancer cells in a more coordinated manner, these novel approaches provide new avenues for treatment, particularly for patients with refractory or relapsed diseases. Challenges and Future Directions Despite the significant progress in antibody drug design, challenges remain. ...
Clinical Trials: Many immuno-oncology services offer access to cutting-edge clinical trials. These trials provide patients with opportunities to participate in research aimed at discovering new therapies and improving existing treatment methods. Participation may offer patients access to the latest advancements in cancer therapy. ...
In many rural and underserved regions, advanced healthcare services are often limited due to factors like a shortage of specialists, long travel distances, and scarce resources. However, technological advancements, especially in mobile health devices, are beginning to bridge these gaps. Mobile ECG (electrocardiogram) devices are at the forefront of this transformation, revolutionizing cardiac ...
ByPanonIT
For healthcare providers looking to enhance patient care while managing expenses, renting mobile ECG (electrocardiogram) devices offers a compelling solution. This approach not only improves patient access to vital heart monitoring but also provides significant benefits for healthcare practices. Here’s why renting mobile ECG devices to ...
ByPanonIT
This provides people with convenience and easy access to healthcare. Remote Patient Monitoring systems have made significant contributions to reducing hospitalization rates, cutting healthcare costs, and enhancing patient outcomes. ...
Effective and Efficient Drug Development Challenge Increased Cost, Risk, and Competition in the Drug Development Processes Dr. Luis Rojas, the Executive Director Head of Biostatistics at Target Health, is a subject matter expert in study design and sample size calculations with more than 30 years of industry experience. He has worked in the leading CROs in the industry and has assisted ...
ByStatsol
Challenge Calculating the appropriate sample size for a first of its kind stage-II colon cancer trial As Chairman of the Department of Biostatistics, Professor Satoshi Teramukai leads a variety of investigator-initiated clinical trials at the Kyoto Prefectural University of Medicine. With over 35 years experience, hundreds of published papers and thousands of citations, Professor Satoshi ...
ByStatsol
To understand the significance of the SpinTech MRI STAGE software platform, it helps to begin by asking a question: Given that MRI is an incredibly powerful diagnostic tool for neurological diseases like Alzheimer’s, dementia, Parkinson’s and multiple sclerosis (MS), why have radiologists and neurologists had to choose between conducting faster MRI exams and obtaining higher-quality ...
Safe’N’Clear is well aware of the importance companies are now placing on diverse suppliers. As companies focus more on diversity, equity, and inclusion (DEI) and on navigating potential supply chain shortages, the focus on diversity and stability in suppliers is increasing. According to a study on DEI in the supply chain industry by Gartner, “While three-quarters of supply ...
The massive collaboration between IT companies, med-tech companies, startups, and healthcare organizations from both public and private sectors, helped to implement telemedicine within shortest span of time. Now, the patients under home-quarantine, individuals experiencing symptoms like Covid19, patients in rural and distant areas can contact doctors to avoid ...
With the emergence of COVID-19, Decentralisation of Clinical Trials became necessary to comply with social distancing requirements while carrying out clinical research. Over the past few years, the clinical trial landscape has shifted its focus to patient-centric practices to promote patient engagement. But now as the pandemic is long gone, it is time to reflect on how DCT studies are genuinely ...
ByClinion
The Clinical CRISPR Successes Are Stacking Up. But Where’s the Emphasis on Quality Control? In mid-September, Intellia released some promising data on two of their CRISPR-based therapeutics. These results are a significant milestone for genome editing and validation of its effectiveness in the clinic. However, the safety of CRISPR-based therapeutics has been a major concern and part of a ...
Medina 1.0.1 bifurcation lesion in the PDA/RPL. Patient had femoral access. After aggressive pre-dilatation of the PDA and vigilant preparation of the RPL with a 2.0/12mm NC balloon. ...
Care management programs, such as PCM, improve patient overall health and reduce emergency room and hospital visits, by making it easier for patients to access their care team, and manage their symptoms to effectively stay on treatment. ...
The randomized phase 2 S1800A study enrolled 136 eligible patients with stage IV or recurrent non-small cell lung cancer. These patients had previously received ICI therapy. In all cases, the patients' tumors eventually became resistant to these drugs and grew or spread before the patients were enrolled in the S1800A trial. ...
With a mission to provide the best patient experience in the industry, the team at Ortho Rhode Island (ORI) is always seeking new ways to enhance their services, so patients not only have confidence that they will have the best outcomes, they can tell that their experience with ORI matters too. In our interview with Dr. Michael Bradley, CEO and President at Ortho Rhode Island, he shares his ...
Erlanger Health System is a nationally acclaimed, multi-hospital health system anchored by a leading academic medical center. Each year, more than 600,000 people are treated by a team of healthcare professionals at seven medical centers across Tennessee and North ...
The comprehensive cancer center designation means patients can access treatments exclusive to Karmanos, as well as clinical trials, cancer prevention programs, and multidisciplinary teams of cancer specialists — a comprehensive approach you cannot find in many large hospitals or health systems. Because comprehensive cancer centers are at the forefront of ...
We believe that the diversity of our staff, including gender diversity, contributes to our company’s success and builds a culture that drives our mission to manufacture simple orthopedic power tools that reduce the cost of surgery and improve access for ...
AMD Awareness Month is a great time to shine a light on this disease and its impact on patients and their families. Perform Dark Adaptation Testing While many patients believe difficulty seeing at night is a sign of old age, it’s also an early symptom of AMD, which occurs most commonly in patients ages 50 and older. ...